Endorsement for scheduled medicines

Endorsement of registration identifies practitioners with additional qualifications and specific expertise. The endorsement available for podiatry is scheduled medicines.

The Podiatry Board of Australia’s revised registration standard for endorsement for scheduled medicines and associated guidelines came into effect on 1 August 2018.

The revised registration standard and guidelines apply to podiatrists and podiatric surgeons applying for endorsement for scheduled medicines after 1 August 2018.

FAQ are available to help practitioners understand the new registration standard and guidelines.

Templates and a Prescribing Self Assessment Tool are also available to support practitioners using Pathway B of the registration standard to endorsement.

Related documents

Document name PDF Accessible format Effective date
Registration standard: Endorsement for scheduled medicines PDF 
(159KB)
Word version 
(95.9KB,DOCX)
1 August 2018
Guidelines: Endorsement for scheduled medicines PDF 
(193KB)
Word version 
(120KB,DOCX)
1 August 2018
FAQ: Endorsement for scheduled medicines PDF 
(415KB)
Web page 1 August 2018
Flowchart: Follow your pathway to endorsement for scheduled medicines PDF 
(50.3KB)
Word version 
(358KB,DOCX)
30 April 2018
Clinical study template Word version 
(363KB,DOCX)
1 August 2018
Prescription template   Word version 
(22.1KB,DOCX)
1 August 2018
Log of activities: Endorsement for scheduled medicines - Pathway B template   Word version 
(74.1KB,DOCX)
1 August 2018
Mentor Agreement (Pathway B) template   Word version 
(355KB,DOCX)
1 August 2018
Certification of completion of supervised practice (Pathway B) template   Word version 
(390KB,DOCX)
1 August 2018
Evidence Matrix - Endorsement for scheduled medicines - Pathway B template   Word version 
(154KB,DOC)
1 August 2018
Prescribing Self-Assessment Tool: Endorsement for scheduled medicines - Pathway B   Word version 
(168KB,DOC)
1 August 2018
Policy: Endorsement for Scheduled Medicines - Extension of time to complete period of supervised practice under Pathway B PDF 
(210KB) 
Word version 
(104KB,DOC)
1 August 2018

Approved online case studies

One of the requirements under Pathway B of the Board’s Registration standard: Endorsement for scheduled medicines (ESM registration standard) is the successful completion of 15 online case studies approved by the Board.

The Board has approved the following online case studies for the purpose of Pathway B of the ESM registration standard:

  1. Web-based case studies offered by LaTrobe University.
  2. Web-based case studies offered by the Queensland University of Technology (QUT) as part of the Graduate Certificate in Podiatric Therapeutics.

Transitional arrangements for practitioners

Recognising that there are practitioners working towards an endorsement under Pathway 2 of the previous registration standard when the new registration standard took effect on 1 August 2018, the Board has developed transitional arrangements.

The transitional arrangements allow these practitioners to continue under Pathway 2 or switch to Pathway B of the new registration standard.

If you are one of these practitioners, there are important timelines you must meet if you want to use the transitional arrangements.

Click on the tile below for information about the transitional arrangements.

Are you using the transitional arrangements? If yes, find out more.

Supplementary information

Copies of documents provided in support of an application, or other purpose required by the National Law, must be certified as true copies of the original documents.

See Certifying Documents on the AHPRA web site.

Ministerial approval letter

Document name PDF Document date
Ministerial letter - Approval of Podiatry Board of Australia's revised Registration standard: Endorsement for scheduled medicines PDF (124KB) 22 February 2018
 
 
Page reviewed 1/08/2018